4//SEC Filing
MABVAX THERAPEUTICS HOLDINGS, INC. 4
Accession 0001415889-17-000591
CIK 0001109196operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:21 PM ET
Size
7.3 KB
Accession
0001415889-17-000591
Insider Transaction Report
Form 4
Varvaro Thomas C
Director
Transactions
- Exercise/Conversion
Common Stock
2017-04-02+1,543→ 3,086 total - Exercise/Conversion
Restricted Stock Unit
2017-04-02−1,543→ 1,543 total→ Common Stock (1,543 underlying)
Footnotes (3)
- [F1]Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015.
- [F2]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer
- [F3]Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001109196
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:21 PM ET
- Size
- 7.3 KB